Drugs / Aventis HOE21PH U400
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 3 | NCT00211536 | Jun 2002 → Aug 2004 | type 1 diabetes mellitus | Medtronic MiniMed, Inc. | Completed | Met primary |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | Aventis HOE21PH U400 | ClinicalTrials.gov intervention name — accepted as the source's own label NCT00211536 ↗ |
| Modality | Protein / enzyme biologic | “Aventis HOE21PH U400 insulin” NCT00211536 ↗ |